BridgeMD
New treatment option for Thoracic Neoplasms
Official title Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung Resection
ClinicalTrials.gov ID: NCT07159659
What this study is testing
- What it's testing
- Lung resection, a critical treatment for various thoracic diseases, including lung cancer, often necessitates prolonged hospitalization due to rare but severe postoperative complications such as chyle leaks, with an occurrence of 0.25%-3%, prolonging chest drainage, and delaying recovery. Therefore, effective postoperative care is essential for optimizing outcomes, reducing complications, and expediting recovery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- General for All procedures:
- Age between 18 - 80 years
- Body mass index \<35 kg/m2
- Suitable for minimally invasive surgery
- Willingness to participate as demonstrated by giving informed consent Project-specific Criteria: 1\. Patients performed lobectomy with lymph node...
You likely can't join if
- Patient general exclusion criteria:
- Contraindication to general anesthesia
- Severe concomitant illness that drastically shortens life expectancy or increases the risk of therapeutic intervention
- Untreated active infection
- Non-correctable coagulopathy
- Emergency surgery
See the full eligibility criteria
- General for All procedures:
- Age between 18 - 80 years
- Body mass index \<35 kg/m2
- Suitable for minimally invasive surgery
- Willingness to participate as demonstrated by giving informed consent Project-specific Criteria: 1\. Patients performed lobectomy with lymph node dissection
- Patient general exclusion criteria:
- Contraindication to general anesthesia
- Severe concomitant illness that drastically shortens life expectancy or increases the risk of therapeutic intervention
- Untreated active infection
- Non-correctable coagulopathy
- Emergency surgery
- Vulnerable population (e.g. mentally disabled, pregnancy) Project-specific Criteria
- Segmentectomy
- Pleurodesis
- Esophageal procedures
- Redo/readmitted patients for lung resection
- Chylothorax (Triglyceride \> 110 mL, excluded at day 1 routine lab check)
- Air leak (\> 30 mL/min when back to ward)
- Heart Failure
- Renal failure (estimated GFR \< 30; CKD grading stage 4-5)
- Moderate to severe adhesion (defined at randomization by surgeon; criteria include estimated surface area of adhesion and staging)
- History of tuberculosis or empyema
The study team makes the final eligibility decision.
Where it's taking place
- Shatin, Hong Kong
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shatin, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.